Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HeartSciences Inc. stock logo
HSCS
HeartSciences
$3.92
+2.3%
$3.60
$2.36
$5.77
$4.14M2.56123,329 shs78,311 shs
LogicMark, Inc. stock logo
LGMK
LogicMark
$0.00
+5.3%
$0.01
$0.00
$24.00
$2.31M1.6749.50 million shs3.61 million shs
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
$3.82
-2.6%
$4.35
$2.43
$16.08
$3.44M1.98649,196 shs15,530 shs
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$0.14
-7.9%
$0.14
$0.06
$6.37
$2.94M0.48580,355 shs4,630 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HeartSciences Inc. stock logo
HSCS
HeartSciences
+2.35%+11.36%-1.01%+38.03%-26.73%
LogicMark, Inc. stock logo
LGMK
LogicMark
+5.26%+2.56%-65.52%-92.16%-99.98%
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
-2.55%-1.55%-7.06%+30.82%-43.54%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
-7.86%+1.90%-10.86%+16.25%-97.66%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
HeartSciences Inc. stock logo
HSCS
HeartSciences
1.9497 of 5 stars
3.53.00.00.00.00.01.3
LogicMark, Inc. stock logo
LGMK
LogicMark
0.2308 of 5 stars
0.03.00.00.00.60.00.6
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
0.3015 of 5 stars
0.04.00.00.00.00.00.6
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
1.6398 of 5 stars
3.03.00.00.00.00.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
HeartSciences Inc. stock logo
HSCS
HeartSciences
3.00
Buy$13.00231.63% Upside
LogicMark, Inc. stock logo
LGMK
LogicMark
0.00
N/AN/AN/A
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
0.00
N/AN/AN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
2.00
Hold$5.003,484.23% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
HeartSciences Inc. stock logo
HSCS
HeartSciences
$20K211.68N/AN/A$11.16 per share0.35
LogicMark, Inc. stock logo
LGMK
LogicMark
$9.88M0.23N/AN/A$148.65 per share0.00
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
$780K4.31N/AN/A$4.55 per share0.84
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$7.68M0.38N/AN/A($6.91) per share-0.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
HeartSciences Inc. stock logo
HSCS
HeartSciences
-$6.61M-$7.48N/AN/AN/AN/A-178.80%-109.28%8/4/2025 (Estimated)
LogicMark, Inc. stock logo
LGMK
LogicMark
-$14.55M-$223.50N/AN/A-141.96%-124.91%-92.05%8/12/2025 (Estimated)
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
N/AN/A0.00N/A-4.07%-0.67%-0.57%8/13/2025 (Estimated)
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
-$50.08MN/A0.00N/A-563.16%N/A-174.06%7/28/2025 (Estimated)

Latest LGMK, HSCS, TIVC, and TTOO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
LogicMark, Inc. stock logo
LGMK
LogicMark
-$0.03-$0.12-$0.09-$0.12$2.23 million$2.59 million
5/15/2025Q1 2025
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
N/A-$2.52N/A-$2.52N/A$0.07 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
HeartSciences Inc. stock logo
HSCS
HeartSciences
N/AN/AN/AN/AN/A
LogicMark, Inc. stock logo
LGMK
LogicMark
N/AN/AN/AN/AN/A
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
N/AN/AN/AN/AN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
HeartSciences Inc. stock logo
HSCS
HeartSciences
N/A
1.02
0.83
LogicMark, Inc. stock logo
LGMK
LogicMark
N/A
3.73
3.29
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
N/A
1.70
1.29
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
N/A
0.40
0.24

Institutional Ownership

CompanyInstitutional Ownership
HeartSciences Inc. stock logo
HSCS
HeartSciences
17.24%
LogicMark, Inc. stock logo
LGMK
LogicMark
7.88%
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
4.25%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
23.18%

Insider Ownership

CompanyInsider Ownership
HeartSciences Inc. stock logo
HSCS
HeartSciences
1.80%
LogicMark, Inc. stock logo
LGMK
LogicMark
1.33%
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
0.51%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
0.03%
CompanyEmployeesShares OutstandingFree FloatOptionable
HeartSciences Inc. stock logo
HSCS
HeartSciences
101.08 million1.06 millionNot Optionable
LogicMark, Inc. stock logo
LGMK
LogicMark
20576.31 million2.65 millionNo Data
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
10880,000874,000Not Optionable
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
18021.04 million21.04 millionOptionable

Recent News About These Companies

TTOO T2 Biosystems, Inc. - Seeking Alpha
T2 Biosystems Inc. (TTOO) After Hours Quote
T2 Biosystems initiates major layoffs, seeks asset sale
T2 Biosystems to be delisted from Nasdaq
T2 Biosystems reports preliminary Q4 revenue $2.3M
T2 Biosystems announces sale of four T2Dx Intruments to European distributor
T2 Biosystems achieves milestone with 250,000th novel sepsis test shipped
T2 Biosystems extends multi-year supplier agreement with Vizient

New MarketBeat Followers Over Time

Media Sentiment Over Time

HeartSciences stock logo

HeartSciences NASDAQ:HSCS

$3.92 +0.09 (+2.35%)
Closing price 06/25/2025 04:00 PM Eastern
Extended Trading
$3.73 -0.19 (-4.85%)
As of 06/25/2025 06:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

LogicMark stock logo

LogicMark NASDAQ:LGMK

$0.0040 +0.00 (+5.26%)
As of 06/25/2025 03:57 PM Eastern

LogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company's devices provide people with the ability to receive care at home and age independently and to check, manage, and monitor a loved one's health and safety remotely. It also manufactures and distributes non-monitored and monitored personal emergency response systems, which are offered through the United States Veterans Health Administration (VHA), direct-to-consumers, healthcare durable medical equipment dealers and distributors, monitored security dealers and distributors, and its ecommerce website logicmark.com and Amazon.com. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky.

Tivic Health Systems stock logo

Tivic Health Systems NASDAQ:TIVC

$3.82 -0.10 (-2.55%)
Closing price 06/25/2025 03:48 PM Eastern
Extended Trading
$3.78 -0.04 (-1.18%)
As of 06/25/2025 06:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

T2 Biosystems stock logo

T2 Biosystems NASDAQ:TTOO

$0.14 -0.01 (-7.86%)
As of 06/25/2025 03:59 PM Eastern

T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.